Kabeer Aziz, Director, 10% Owner at AN2 Therapeutics, Inc. (ANTX), sold 400 shares at $16.00 ($6K) on 2023-09-13, disclosed to the SEC on 2023-09-15.
Scheduled sale ($6k) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 64 | $1K | 16.0% |
| 2 | $16.00 | 336 | $5K | 84.0% |
| Total | $16.00 avg | 400 | $6K | 100% |
| Filing → |
| ANTX | SELL | 2023-10-03 | $3.4M | — | Filing → |
| ANTX | SELL | 2023-09-29 | $266K | — | Filing → |
| ANTX | SELL | 2023-09-08 | $165K | — | Filing → |